KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Cash & Equivalents (2016 - 2026)

Evolent Health has reported Cash & Equivalents over the past 11 years, most recently at $151.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 45.73% year-over-year to $151.9 million; the TTM value through Dec 2025 reached $151.9 million, up 45.73%, while the annual FY2025 figure was $151.9 million, 45.73% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $151.9 million at Evolent Health, up from $116.7 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $266.3 million in Q4 2021 and troughed at $96.6 million in Q3 2024.
  • A 5-year average of $176.0 million and a median of $174.8 million in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 247.34% in 2021 and later plummeted 47.66% in 2024.
  • Year by year, Cash & Equivalents stood at $266.3 million in 2021, then dropped by 29.32% to $188.2 million in 2022, then increased by 2.46% to $192.8 million in 2023, then plummeted by 45.96% to $104.2 million in 2024, then skyrocketed by 45.73% to $151.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for EVH at $151.9 million in Q4 2025, $116.7 million in Q3 2025, and $151.0 million in Q2 2025.